miRNAs Caught Up in Metabolic Organ Crosstalk to Combat Obesity  by Ntambi, James M.
EBioMedicine 5 (2016) 10–11
Contents lists available at ScienceDirect
EBioMedicine
j ourna l homepage: www.eb iomed ic ine.comCommentarymiRNAs Caught Up in Metabolic Organ Crosstalk to Combat ObesityJames M. Ntambi
Department of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive Madison, WI 53706, USADOI of original article: http://dx.doi.org/10.1016/j.ebio
E-mail address: james.ntambi@wisc.edu.
http://dx.doi.org/10.1016/j.ebiom.2016.03.007
2352-3964/© 2016 The Author. Published by Elsevier B.Va r t i c l e i n f oAvailable online 8 March 2016EBioMedicine, Zhang et al., 2016-in this issue present a potentially inter-
esting study investigating the role of a speciﬁcmiRNA, miR-378, inmet-
abolic regulation.
In thepresentwork, Zhang et al., 2016-in this issuedescribe a complex
hyper metabolic phenotype arising from whole body overexpression ofObesity has reached epidemic proportions globally as a public health
problem and is a major contributor to the development of metabolic
disease, including type II diabetes, coronary heart disease, hypertension,
osteoarthritis, fatty liver disease, inﬂammation, sleep apnea and certain
cancers. Currently there are no effective drugs for the treatment of
obesity.
Obesity is a multifactorial condition stemming from a combination of
genetic, dietary, and environmental factors and the interaction between
these components. The precise etiology of the many abnormalities that
occur in obesity is still unknown; however, an increasingbodyof evidence
supports the Barker hypothesis that their true origins may actually occur
in utero (Barker et al. 1990). Themost widely acceptedmechanism is that
of fetal programming by nutritional stimuli due to changes in epigenetic
modiﬁcation of gene expression.
There are also many studies that show that several manifestations of
the metabolic syndrome are associated with alterations in intracellular
lipid and carbohydratemetabolism (Burhans andNtambi 2016). It is gen-
erally undisputed that excess adipose tissue increases one's risk for the
development ofmetabolic dysfunction.More speciﬁcally, visceral adipos-
ity is now recognized as one of the strongest predictors of ectopic fat
accumulation in tissues other than in adipose, such as in the liver and
muscle.
The mechanisms that connect increased adiposity to the develop-
ment of other metabolic diseases continue to be actively investigated.
Perhaps unsurprisingly, much attention has focused on the role of se-
creted molecules that regulate metabolism systemically. While many
of these secreted factors are peptides with well described target tissues,
receptor partners and signaling cascades, recently there has also been
an emergence of reports of non-protein factors, including speciﬁc lipids
and fatty acids that control metabolic processes (Cao et al. 2008; Liu
et al. 2013).
More recently, micro RNAs (miRNAs), small non-coding RNA mole-
cules containing about 22 nucleotides that are found inmany organisms
andmainly function in the regulation of gene expression have emerged
as key regulators of metabolism (Liu et al. 2014). In the current issue ofm.2016.01.035.
. This is an open access article undermiR-378 in mice. miR-378 can apparently prevent and treat obesity by
activating the muscle pyruvate-phosphoenolpyruvate (pyruvate-PEP)
futile cycle by targeting the Akt1-Foxo1-PEPCK pathway and enhancing
lipolysis in adipose tissue. Activation of the futile cycle by miR-378
leads to impairment of glucose metabolism because, under these condi-
tions, the pyruvate from glycolysis does not enter the tricarboxylic acid
(TCA) cycle. Instead, it is converted back into PEP in a gluconeogenic
reaction catalyzed by phosphoenolpyruvate carboxykinase (PEPCK) and
pyruvate kinase (PC),which costs ATP andproduces an energy deﬁciency.
As consequence more energy from adipose tissue lipolysis is needed to
balance energy homeostasis.
Zhang et al., 2016-in this issue attribute the elevated lipolysis to the
miRNA-378-mediated decrease in expression of stearoyl-CoA
desaturase-1 (SCD1) in adipose tissue. SCD1 catalyzes the synthesis of
monounsaturated fatty acids from saturated fatty acids, mainly palmi-
tate and stearate into palmitoleate and oleate, respectively (Ntambi
1995). Global knockout of SCD1 in mice displays a similar phenotype
to that ofmiR-378 transgenicmice, including a lean body phenotype, el-
evated lipolysis and increased energy expenditure (Sampath and
Ntambi 2014). However, adipose tissue speciﬁc knockout of SCD1
does not affect lipolysis, (Flowers et al., 2012) suggesting that miR-
378 may be targeting SCD1 expression in other tissues. Alternately,
other mechanisms involved in miR-378-mediated adipocyte lipolysis
that have been reported (Kulyte et al. 2014) could be responsible. Fur-
ther, the role of miR-378 in regulatingmolecules that promote lipolysis,
including adrenaline, glucagon, thyroid hormone, adipokines, and
hepatokines, that signal energy insufﬁciency and mediate inter-organ
cross talk could also contribute to the mechanism of miR-378 in main-
tainingwhole body energy homeostasis. It will also be interesting to de-
termine whether miR-378 overexpression causes an inﬂammatory
response, which is known to induce lipolysis in adipose tissue.
In general, the data by Zhang et al., 2016-in this issue suggest that
the regulation of futile cycles is important in maintaining whole body
metabolic homeostasis. Futile cycles are typically regarded as energeti-
cally wasteful processes that are avoided inmetabolic pathways. Not so
any more. The miR-378-activated pyruvate-phosphoenolpyruvate fu-
tile cycle is the primary cause of elevated lipolysis in adipose tissues
and helps orchestrate inter-organ crosstalk between skeletal musclethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
11J.M. Ntambi / EBioMedicine 5 (2016) 10–11and fat to control systemic energy homeostasis in mice. Thus, miR-378
could be implicated in preventing and treating obesity in humans.
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